| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 12/26/2001 | CN1327830A Quick-acting vagine contraction medicine and its preparing process |
| 12/26/2001 | CN1327818A Antiabortifacient for treating acyesis and sterility and its preparing process |
| 12/26/2001 | CN1327817A Antiabortifacient for treating male endocrine sterility and its preparing process |
| 12/26/2001 | CN1327816A Antiabortifacient for treating acyesis and sterility and its preparing process |
| 12/26/2001 | CN1327800A Composite Chinese medicine for treating prostatitis, impotence and ejaculation praecox and its preparing process |
| 12/26/2001 | CN1327794A Vaginal minocycline suppository |
| 12/26/2001 | CN1327793A Pyrrolo-triazine and pyrimidine compounds |
| 12/26/2001 | CN1076612C Chinese-medicinal instant particles for promoting milk secretion and recovery of puerperant |
| 12/25/2001 | US6333350 Use of nitric oxide donors and/or substrates or nitric oxide inhibitors for regulating cervical dilatation and extensibility |
| 12/25/2001 | US6333343 Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents |
| 12/25/2001 | CA2233753C Drug delivery system for two or more active substances |
| 12/25/2001 | CA2081348C Veterinary formulation of amoxycillin and clavulanic acid, and derivatives thereof |
| 12/22/2001 | CA2312252A1 5,6,7-trinor-4, 8-inter-m-phenylene pgi2 derivative and medicine containing the same |
| 12/20/2001 | WO2001096547A2 Human kinases |
| 12/20/2001 | WO2001096546A2 Protein phosphatases |
| 12/20/2001 | WO2001096393A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/20/2001 | WO2001096347A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD |
| 12/20/2001 | WO2001096331A1 Lactam inhibitors of factor xa and method |
| 12/20/2001 | WO2001096311A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 12/20/2001 | WO2001096305A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096302A1 Piperidines for use as orexin receptor antagonists |
| 12/20/2001 | WO2001095938A1 Preventives/remedies for granuloma |
| 12/20/2001 | WO2001095893A1 Use of an epoxy-steroidal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 12/20/2001 | WO2001095892A1 Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects |
| 12/20/2001 | WO2001095785A2 Modulation of immune response and methods based thereon |
| 12/20/2001 | WO2001085197A8 Method for curing diffusive masthopaty |
| 12/20/2001 | WO2001064192A3 Use of benzothieno-2,3-d-pyrimidines with pde v inhibitory effect for the treatment of erectile dysfunction |
| 12/20/2001 | WO2001052835A3 Free radical scavengers for the treatment of premature birth |
| 12/20/2001 | WO2001044207A3 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 12/20/2001 | WO2001016108A3 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 12/20/2001 | WO2000072832A3 Novel use of 1-[4-(cyanoindol-3yl)butyl]-4-(carbamoyl-benzofuran-5yl)-piperazine and its physiologically acceptable salts |
| 12/20/2001 | US20010053765 Methods and compositions for the selective regulation of chorionic prostanoids |
| 12/20/2001 | US20010053536 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor |
| 12/20/2001 | US20010053363 Novel amphipathic aldehydes and their uses as adjuvants and immunoeffectors |
| 12/20/2001 | US20010053357 Peptide having an amino acid sequence corresponding to an amino acid sequence of a V-domain of a receptor for advanced glycation endproduct. |
| 12/20/2001 | CA2412979A1 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 12/20/2001 | CA2412632A1 Hmg-coa reductase inhibitors and method |
| 12/20/2001 | CA2412216A1 Lactam inhibitors of factor xa and method |
| 12/20/2001 | CA2410610A1 Human kinases |
| 12/20/2001 | CA2410532A1 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/20/2001 | CA2409315A1 Protein phosphatases |
| 12/20/2001 | CA2407699A1 Use of an aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 12/19/2001 | EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites |
| 12/19/2001 | EP1163259A1 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens |
| 12/19/2001 | EP1163258A1 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis |
| 12/19/2001 | EP1163255A1 50 human secreted proteins |
| 12/19/2001 | EP1163244A1 Thienopyrimidine compounds, their production and use |
| 12/19/2001 | EP1163239A1 Modified amino-acid amides as cgrp antagonists |
| 12/19/2001 | EP1163226A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 12/19/2001 | EP1163225A1 Compounds and methods for modulation of estrogen receptors |
| 12/19/2001 | EP1163213A1 Hydroxamic and carboxylic acid derivatives |
| 12/19/2001 | EP1163009A1 Gel-microemulsion formulations |
| 12/19/2001 | EP1162988A1 Wafer delivery system |
| 12/19/2001 | EP1162984A2 Use of cross linked polysaccharides for the inhibition of angiogenesis |
| 12/19/2001 | EP1162977A1 (androst-5-en-17beta-yl)alkyl sulfoxides and sulfones and their use for the control of fertility |
| 12/19/2001 | EP1162969A2 Compositions for improving fertility |
| 12/19/2001 | EP1162880A1 Human sperm surface antigens |
| 12/19/2001 | EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/19/2001 | EP0859778B1 TETRAHYDROIMIDAZOPYRIDOINDOLEDIONES AS INHIBITORS OF cGMP SPECIFIC PDE |
| 12/19/2001 | EP0785781B1 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation |
| 12/19/2001 | EP0493485B1 Erection-inducing methods and compositions |
| 12/19/2001 | CN1326780A Medicinal capsule for cuirng male sterility and its preparing process |
| 12/19/2001 | CN1326763A Pure Chinese medicine prepn. for fast strengthening yang and tonifying kidney |
| 12/19/2001 | CN1326748A Tincture for curing male's sexual function disturbance and its preparing process |
| 12/19/2001 | CN1326741A Minocycline vaginal powder |
| 12/19/2001 | CN1326740A Minocycline vaginal solution agent |
| 12/19/2001 | CN1326739A Minocycline vaginal gel |
| 12/19/2001 | CN1326738A Minocycline vaginal effervescent tablets |
| 12/19/2001 | CN1076348C 3-bustituted oxindole derivatives as patassium path regulating agent |
| 12/18/2001 | US6331637 N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 12/18/2001 | US6331571 Methods of treating and preventing attention deficit disorders |
| 12/18/2001 | CA2202484C Use of indole derivatives for the treatment of various diseases |
| 12/13/2001 | WO2001094621A1 Screening method for modulators of suv39h2-methyltransferase |
| 12/13/2001 | WO2001094620A1 Screening-method for modulators of methyltransferase-dependent chromosome stability |
| 12/13/2001 | WO2001094415A2 Nuclear hormone receptor |
| 12/13/2001 | WO2001094391A2 Intracellular signaling proteins |
| 12/13/2001 | WO2001094387A2 Epididymis-specific proteins with fibronectin type ii modules |
| 12/13/2001 | WO2001094369A2 Heterocycle derivatives and methods of use for treating anthrax infection |
| 12/13/2001 | WO2001094368A1 2-aminocarbonyl-9h-purine derivatives |
| 12/13/2001 | WO2001094350A1 6-phenylpyrrolopyrimidinedione derivatives |
| 12/13/2001 | WO2001094347A1 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 12/13/2001 | WO2001094345A2 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 12/13/2001 | WO2001094319A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
| 12/13/2001 | WO2001094307A1 Propanolaminotetralines, preparation thereof and compositions containing same |
| 12/13/2001 | WO2001093912A1 Vaccine |
| 12/13/2001 | WO2001093911A2 Macromolecular drug complexes and compositions containing the same |
| 12/13/2001 | WO2001093848A2 Starter kit for low dose oral contraceptives |
| 12/13/2001 | WO2001072772A3 Calcium binding regulatory subunit |
| 12/13/2001 | WO2001044445A3 Human lyases and associated proteins |
| 12/13/2001 | WO2001044228A3 Derivatives of quinazolinedione phthalimide, preparations thereof and their therapeutic uses |
| 12/13/2001 | WO2001044200A3 Selective neurokinin antagonists |
| 12/13/2001 | WO2001034171A3 Peptides for treatment of erectile dysfunction |
| 12/13/2001 | US20010051656 Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction |
| 12/13/2001 | US20010051626 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 12/13/2001 | US20010051623 8-(Piperidin-4-yl- or piperazin-1-yl)-2-substituted-tetralin derivatives; selective effect at a subgroup of 5-hydroxytryptamine receptors, h5-HT1B receptors (previously 5-HT1D beta); antagonists; mood disorders, antianxiolytic |
| 12/13/2001 | US20010051604 Mixture containing stabilizers, sodium chloride, buffer and surfactants |
| 12/13/2001 | DE10027170A1 Humanes PEM als Target für die Fertilitätskontrolle Human PEM as a target for fertility control |
| 12/13/2001 | CA2411351A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
| 12/13/2001 | CA2411017A1 Epididymis-specific proteins with fibronectin type ii modules |
| 12/13/2001 | CA2411013A1 6-phenylpyrrolopyrimidinedione derivatives |